Product Information
BENZONATATE 200 MG CAPSULE is a generic product labeled by Bionpharma Inc., priced at $0.1013 per EA under NDC 69452014430. Its NADAC has been published 501 times since Mar 1, 2017.
FDA first approved this application on Jan 29, 1993. Its Orange Book therapeutic-equivalence code is AA.
Strength
200 mg/1
Manufacturer
Bionpharma Inc.NDC
69452014430
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENZONATATEApproval Type
Generic (ANDA)
FDA Application
ANDA081297FDA Approved
1/29/1993
TE Code
AA
On Market Since
8/15/2016
Pharmacological Classes
Price Statistics
The NADAC for BENZONATATE 200 MG CAPSULE has been published 501 times since Mar 1, 2017, and over the history we have for it it has declined 68.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1013 per EA |
|---|---|
| All-time high | $0.3313 (Apr 12, 2017) |
| All-time low | $0.0829 (Nov 20, 2024) |
| 52-week high | $0.1086 |
| 52-week low | $0.1013 |
| Median price | $0.1329 |
| Average price | $0.1515 |
| Largest weekly change | -30.2% (Nov 20, 2024) |
| Weeks tracked | 501 |
| Tracking since | Mar 1, 2017 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benzonatate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-narcotic Antitussive class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENZONATATE 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BENZONATATE 200 MG CAPSULE, manufactured by Bionpharma Inc., is $0.1013 per EA (NDC 69452014430), effective Sep 30, 2026.
How has the price of BENZONATATE 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BENZONATATE 200 MG CAPSULE has declined 68.0%. It has been tracked across 501 weekly CMS publications since Mar 1, 2017.
What are the highest and lowest recorded NADAC prices for BENZONATATE 200 MG CAPSULE?
Since Mar 1, 2017, the NADAC for BENZONATATE 200 MG CAPSULE has ranged from a low of $0.0829 (Nov 20, 2024) to a high of $0.3313 (Apr 12, 2017), with a median of $0.1329 per EA.
Are there cheaper alternatives to BENZONATATE 200 MG CAPSULE?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENZONATATE 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BENZONATATE 200 MG CAPSULE?
BENZONATATE 200 MG CAPSULE (NDC 69452014430) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.